The documentary, “The Resilient Brain,” explores the complexity of the human brain across the lifespan, and features neuroscientists including Gavin Rumbaugh, Ph.D., of The Wertheim UF Scripps Institute.
GatorPitch Jupiter will be held March 5, 2026, at The Wertheim UF Scripps Institute in Jupiter, Florida.
Compounds able to reprogram insulin-resistant cells into a healthier state, with reduced side effects, are described in a new paper from Griffin lab.
Kendall Nettles, Ph.D., applies detailed 3-D views and computer models to reveal how hormones, the body’s chemical messengers, and their receptors work. The goal? To tackle real‑world medical problems, including cancer drug resistance. Nettles’ lab works to translate molecular-level discoveries into better, safer medicines. Exploring the…
Timothy Spicer, Ph.D., and Louis Scampavia, Ph.D., use robotics and biochemistry to unearth potential new medicines. When scientists discover something new about a disease, it presents an exciting opportunity to find a new treatment. But where to start? Discovering the needle in the haystack…
An FDA‑approved medication called spironolactone, often prescribed as a diuretic, or water pill, for heart and blood pressure conditions, may be a useful add‑on to the standard HIV treatment, a new study shows.
The Journey from Molecule to Medicine – A Photo Tour From molecules to medicines, every cure begins with understanding. At the Wertheim UF Scripps Institute, we unlock tomorrow’s therapies by understanding the complexity of life. “We can also apply this to areas of unmet need that maybe a pharmaceutical…
Mapping vulnerabilities in the SARS-CoV-2 genome, made of RNA, reveals a path to fighting more than COVID-19.
Liu’s research focuses on the discovery of small molecules for human proteins, as well as the functional characterization of these proteins in physiological and disease contexts.
Half of glioblastoma patients have a subtype that doesn’t respond to any approved cancer drugs. A new experimental treatment from The Wertheim UF Scripps Institute shows promise in mouse studies. Clinical trials are coming soon.
